Silexion Therapeutics (SLXN) Research & Development (2023 - 2026)
Silexion Therapeutics' Research & Development was $2.21 million in Q2 2026, up 117.3% from $1.02 million a year earlier and up 61.5% from the prior quarter.
Powered by 
Analysis
Silexion Therapeutics (SLXN) Research & Development (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Silexion Therapeutics' Research & Development was $9.11 million through Jun 30, 2026, up 60.0% year-over-year; for FY2025, it came in at $7.14 million, up 22.8% from FY2024.
- In earlier years, Research & Development was $5.82 million in FY2024 (+56.8%) and $3.71 million in FY2023.
- Quarterly Research & Development has moved between $535,000 (Q3 2023) and $3.38 million (Q4 2025) over five years.
- Compared with a year earlier, Research & Development has increased for three straight quarters, with growth averaging 121.1% over the last eight quarters.
- The best year-over-year quarter for Research & Development over five years was Q3 2024 (growth of 501.3%); the worst was Q1 2025 (a decline of 38.6%).
- Per Business Quant data, SLXN's Research & Development in the three quarters before Q2 2026 was $1.37 million (Q1 2026), $3.38 million (Q4 2025) and $2.16 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Silexion Therapeutics | 219,952.96 | -19.66 Mn | - | 2.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.21 Mn |
| Mar 31, 2026 | 1.37 Mn |
| Dec 31, 2025 | 3.38 Mn |
| Sep 30, 2025 | 2.16 Mn |
| Jun 30, 2025 | 1.02 Mn |
| Mar 31, 2025 | 590,000.00 |
| Dec 31, 2024 | 871,000.00 |
| Sep 30, 2024 | 3.22 Mn |
| Jun 30, 2024 | 766,000.00 |
| Mar 31, 2024 | 961,000.00 |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | 535,000.00 |
| Jun 30, 2023 | 1.24 Mn |
API Access
Silexion Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=SLXN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "SLXN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=SLXN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();